This report provides a comprehensive analysis of the global Streptavidin SPR Chip market, projecting steady growth through 2032. It examines key segments including pre-immobilized and regenerable chips across various platform formats like Biacore and Octet. Driven by increasing demand in biopharmaceutical R&D, antibody characterization, and small-molecule screening, the market benefits from the high-affinity biotin-streptavidin system. The study evaluates competitive dynamics among leading manufacturers, regional market trends, and evolving technological opportunities in drug discovery.

Market Overview

The global Streptavidin SPR Chip market is projected to grow from US$ 51.85 million in 2025 to US$ 84.40 million in 2032, representing a compound annual growth rate (CAGR) of 7.5% from 2026 to 2032. The market is expected to maintain moderate growth that exceeds the overall life science consumables market.

Product Definition and Technical Specifications

Streptavidin SPR chips are Surface Plasmon Resonance (SPR) consumables featuring streptavidin that is either pre-immobilized or forms a streptavidin capture layer on gold films, prisms, or sensor substrates via accompanying reagents.

• Primary Function: They are utilized for the high-affinity capture of biotinylated proteins, peptides, nucleic acids, glycans, and other ligands.
• Analytical Capabilities: They enable affinity, kinetics, and screening analyses.
• Economic Profile: The product maintains a gross margin of approximately 62%.
• Market Positioning: While not as general-purpose as CM5/CM-dextran chips and possessing a smaller market size, SA chips command high unit prices and exhibit clear repurchase patterns. They are indispensable for antibody screening, nucleic acid aptamers, membrane protein analyses, and biotinylated targets.

Market Dynamics

Demand Drivers

Demand is primarily driven by the requirements of drug discovery for high-throughput, low-sample-volume, and renewable capture surfaces. Key demand sectors include:

• Biopharmaceutical R&D
• CRO testing
• Antibody/ADC characterization
• Early-stage small-molecule screening

The streptavidin–biotin system is highly valued for its high affinity and superior oriented immobilization, making it ideal for ligands that require directional capture, are susceptible to inactivation after covalent coupling, or necessitate stable, long-term repeated injections.

Supply Side and Competitive Landscape

The market consists of a mix of platform-bound and compatible chips:

• Instrument Vendors: Companies such as Cytiva and Sartorius utilize their installed base and validation systems to maintain high pricing.
• Specialized Surface Suppliers: Providers like XanTec, BioNavis, and Reichert meet replacement demand through various matrices, capacities, and compatible formats.
• Regional Supply Trends: Domestic SPR platforms are beginning to offer SA chips, though they currently remain in the stage of platform adaptation and import substitution.

Market Segmentation

By Type

• Pre-Immobilized Streptavidin
• On-Chip Streptavidin Kit
• Regenerable Streptavidin
• Custom Streptavidin Surface
• Other Capture Surface

By Platform Format

• Biacore Format
• Octet SPR Format
• OpenSPR Format
• MP-SPR Slide
• SPRi Array Format
• Other Format

By Capture Capacity

• Low Capacity
• Medium Capacity
• High Capacity
• Very High Capacity
• Custom Capacity

By Application

• Protein Kinetics
• Small-Molecule Screening
• Antibody Characterization
• Nucleic Acid Binding
• Peptide Binding
• Biomarker Assay Development
• Biosensor Surface Development

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Key Companies

The following companies are profiled based on expert input, product portfolio, coverage, and market penetration:

• Cytiva
• Sartorius
• Nicoya
• XanTec
• BioNavis
• Biosensing Instrument
• Reichert
• Carterra
• Malvern Panalytical
• Polariton Life

About the Research Report

The "Streptavidin SPR Chip Industry Forecast" by LP Information, Inc. (LPI) provides a comprehensive analysis of the global Streptavidin SPR Chip landscape.

• Scope: The report reviews total global sales for 2025 and provides projected sales analysis for the period of 2026 through 2032, broken down by region, market sector, and sub-sector in US$ millions.
• Analytical Focus: It highlights key trends in product segmentation, company formation, revenue, market share, latest developments, and M&A activity. It also examines leading companies' strategies regarding portfolios, capabilities, market entry, market positions, and geographic footprints.
• Methodology: The study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to provide a nuanced view of the market's current state and future trajectory.

Key Questions Addressed

• What is the 10-year outlook for the global Streptavidin SPR Chip market?
• What factors are driving Streptavidin SPR Chip market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Streptavidin SPR Chip market opportunities vary by end market size?
• How does Streptavidin SPR Chip break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Streptavidin SPR Chip Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Streptavidin SPR Chip by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Streptavidin SPR Chip by Country/Region, 2021, 2025 & 2032

  • 2.2 Streptavidin SPR Chip Segment by Type

    • 2.2.1 Pre-Immobilized Streptavidin

    • 2.2.2 On-Chip Streptavidin Kit

    • 2.2.3 Regenerable Streptavidin

    • 2.2.4 Custom Streptavidin Surface

    • 2.2.5 Other Capture Surface

    • 2.2.6 Streptavidin SPR Chip Sales by Type

      • 2.2.6.1 Global Streptavidin SPR Chip Sales Market Share by Type (2021-2026)
      • 2.2.6.2 Global Streptavidin SPR Chip Revenue and Market Share by Type (2021-2026)
      • 2.2.6.3 Global Streptavidin SPR Chip Sale Price by Type (2021-2026)

  • 2.3 Streptavidin SPR Chip Segment by Platform Format

    • 2.3.1 Biacore Format

    • 2.3.2 Octet SPR Format

    • 2.3.3 OpenSPR Format

    • 2.3.4 MP-SPR Slide

    • 2.3.5 SPRi Array Format

    • 2.3.6 Other Format

    • 2.3.7 Streptavidin SPR Chip Sales by Platform Format

      • 2.3.7.1 Global Streptavidin SPR Chip Sales Market Share by Platform Format (2021-2026)
      • 2.3.7.2 Global Streptavidin SPR Chip Revenue and Market Share by Platform Format (2021-2026)
      • 2.3.7.3 Global Streptavidin SPR Chip Sale Price by Platform Format (2021-2026)

  • 2.4 Streptavidin SPR Chip Segment by Capture Capacity

    • 2.4.1 Low Capacity

    • 2.4.2 Medium Capacity

    • 2.4.3 High Capacity

    • 2.4.4 Very High Capacity

    • 2.4.5 Custom Capacity

    • 2.4.6 Streptavidin SPR Chip Sales by Capture Capacity

      • 2.4.6.1 Global Streptavidin SPR Chip Sales Market Share by Capture Capacity (2021-2026)
      • 2.4.6.2 Global Streptavidin SPR Chip Revenue and Market Share by Capture Capacity (2021-2026)
      • 2.4.6.3 Global Streptavidin SPR Chip Sale Price by Capture Capacity (2021-2026)

  • 2.5 Streptavidin SPR Chip Segment by Application

    • 2.5.1 Protein Kinetics

    • 2.5.2 Small-Molecule Screening

    • 2.5.3 Antibody Characterization

    • 2.5.4 Nucleic Acid Binding

    • 2.5.5 Peptide Binding

    • 2.5.6 Biomarker Assay Development

    • 2.5.7 Biosensor Surface Development

    • 2.5.8 Streptavidin SPR Chip Sales by Application

      • 2.5.8.1 Global Streptavidin SPR Chip Sale Market Share by Application (2021-2026)
      • 2.5.8.2 Global Streptavidin SPR Chip Revenue and Market Share by Application (2021-2026)
      • 2.5.8.3 Global Streptavidin SPR Chip Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Streptavidin SPR Chip Breakdown Data by Company

    • 3.1.1 Global Streptavidin SPR Chip Annual Sales by Company (2021-2026)

    • 3.1.2 Global Streptavidin SPR Chip Sales Market Share by Company (2021-2026)

  • 3.2 Global Streptavidin SPR Chip Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Streptavidin SPR Chip Revenue by Company (2021-2026)

    • 3.2.2 Global Streptavidin SPR Chip Revenue Market Share by Company (2021-2026)

  • 3.3 Global Streptavidin SPR Chip Sale Price by Company

  • 3.4 Key Manufacturers Streptavidin SPR Chip Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Streptavidin SPR Chip Product Location Distribution

    • 3.4.2 Players Streptavidin SPR Chip Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Streptavidin SPR Chip by Geographic Region

  • 4.1 World Historic Streptavidin SPR Chip Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Streptavidin SPR Chip Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Streptavidin SPR Chip Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Streptavidin SPR Chip Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Streptavidin SPR Chip Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Streptavidin SPR Chip Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Streptavidin SPR Chip Sales Growth

  • 4.4 APAC Streptavidin SPR Chip Sales Growth

  • 4.5 Europe Streptavidin SPR Chip Sales Growth

  • 4.6 Middle East & Africa Streptavidin SPR Chip Sales Growth

• 5 Americas

  • 5.1 Americas Streptavidin SPR Chip Sales by Country

    • 5.1.1 Americas Streptavidin SPR Chip Sales by Country (2021-2026)

    • 5.1.2 Americas Streptavidin SPR Chip Revenue by Country (2021-2026)

  • 5.2 Americas Streptavidin SPR Chip Sales by Type (2021-2026)

  • 5.3 Americas Streptavidin SPR Chip Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Streptavidin SPR Chip Sales by Region

    • 6.1.1 APAC Streptavidin SPR Chip Sales by Region (2021-2026)

    • 6.1.2 APAC Streptavidin SPR Chip Revenue by Region (2021-2026)

  • 6.2 APAC Streptavidin SPR Chip Sales by Type (2021-2026)

  • 6.3 APAC Streptavidin SPR Chip Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Streptavidin SPR Chip by Country

    • 7.1.1 Europe Streptavidin SPR Chip Sales by Country (2021-2026)

    • 7.1.2 Europe Streptavidin SPR Chip Revenue by Country (2021-2026)

  • 7.2 Europe Streptavidin SPR Chip Sales by Type (2021-2026)

  • 7.3 Europe Streptavidin SPR Chip Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Streptavidin SPR Chip by Country

    • 8.1.1 Middle East & Africa Streptavidin SPR Chip Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Streptavidin SPR Chip Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Streptavidin SPR Chip Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Streptavidin SPR Chip Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Streptavidin SPR Chip

  • 10.3 Manufacturing Process Analysis of Streptavidin SPR Chip

  • 10.4 Industry Chain Structure of Streptavidin SPR Chip

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Streptavidin SPR Chip Distributors

  • 11.3 Streptavidin SPR Chip Customer

• 12 World Forecast Review for Streptavidin SPR Chip by Geographic Region

  • 12.1 Global Streptavidin SPR Chip Market Size Forecast by Region

    • 12.1.1 Global Streptavidin SPR Chip Forecast by Region (2027-2032)

    • 12.1.2 Global Streptavidin SPR Chip Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Streptavidin SPR Chip Forecast by Type (2027-2032)

  • 12.7 Global Streptavidin SPR Chip Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Cytiva

    • 13.1.1 Cytiva Company Information

    • 13.1.2 Cytiva Streptavidin SPR Chip Product Portfolios and Specifications

    • 13.1.3 Cytiva Streptavidin SPR Chip Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Cytiva Main Business Overview

    • 13.1.5 Cytiva Latest Developments

  • 13.2 Sartorius

    • 13.2.1 Sartorius Company Information

    • 13.2.2 Sartorius Streptavidin SPR Chip Product Portfolios and Specifications

    • 13.2.3 Sartorius Streptavidin SPR Chip Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Sartorius Main Business Overview

    • 13.2.5 Sartorius Latest Developments

  • 13.3 Nicoya

    • 13.3.1 Nicoya Company Information

    • 13.3.2 Nicoya Streptavidin SPR Chip Product Portfolios and Specifications

    • 13.3.3 Nicoya Streptavidin SPR Chip Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Nicoya Main Business Overview

    • 13.3.5 Nicoya Latest Developments

  • 13.4 XanTec

    • 13.4.1 XanTec Company Information

    • 13.4.2 XanTec Streptavidin SPR Chip Product Portfolios and Specifications

    • 13.4.3 XanTec Streptavidin SPR Chip Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 XanTec Main Business Overview

    • 13.4.5 XanTec Latest Developments

  • 13.5 BioNavis

    • 13.5.1 BioNavis Company Information

    • 13.5.2 BioNavis Streptavidin SPR Chip Product Portfolios and Specifications

    • 13.5.3 BioNavis Streptavidin SPR Chip Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 BioNavis Main Business Overview

    • 13.5.5 BioNavis Latest Developments

  • 13.6 Biosensing Instrument

    • 13.6.1 Biosensing Instrument Company Information

    • 13.6.2 Biosensing Instrument Streptavidin SPR Chip Product Portfolios and Specifications

    • 13.6.3 Biosensing Instrument Streptavidin SPR Chip Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Biosensing Instrument Main Business Overview

    • 13.6.5 Biosensing Instrument Latest Developments

  • 13.7 Reichert

    • 13.7.1 Reichert Company Information

    • 13.7.2 Reichert Streptavidin SPR Chip Product Portfolios and Specifications

    • 13.7.3 Reichert Streptavidin SPR Chip Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Reichert Main Business Overview

    • 13.7.5 Reichert Latest Developments

  • 13.8 Carterra

    • 13.8.1 Carterra Company Information

    • 13.8.2 Carterra Streptavidin SPR Chip Product Portfolios and Specifications

    • 13.8.3 Carterra Streptavidin SPR Chip Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Carterra Main Business Overview

    • 13.8.5 Carterra Latest Developments

  • 13.9 Malvern Panalytical

    • 13.9.1 Malvern Panalytical Company Information

    • 13.9.2 Malvern Panalytical Streptavidin SPR Chip Product Portfolios and Specifications

    • 13.9.3 Malvern Panalytical Streptavidin SPR Chip Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Malvern Panalytical Main Business Overview

    • 13.9.5 Malvern Panalytical Latest Developments

  • 13.10 Polariton Life

    • 13.10.1 Polariton Life Company Information

    • 13.10.2 Polariton Life Streptavidin SPR Chip Product Portfolios and Specifications

    • 13.10.3 Polariton Life Streptavidin SPR Chip Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 Polariton Life Main Business Overview

    • 13.10.5 Polariton Life Latest Developments

• 14 Research Findings and Conclusion